United Healthcare Targets Multiple Firms Over US Pricing
Executive Summary
The generics industry’s biggest companies are once again in the crosshairs of a US lawsuit over pricing, after insurer United Healthcare alleged a series of conspiracies between major players involving 30 different generic molecules or combinations.
You may also be interested in...
AAM's Davis Cautions Against 'Court Of Public Opinion' On Price-Fixing Claims
The AAM’s president and CEO, Chip Davis, has made a television appearance to respond to media coverage of the latest multi-state US lawsuit alleging price-fixing within the US generics industry.
Further US Lawsuit Claims Price-Fixing Conspiracy
Teva, along with Mylan, Pfizer, Sandoz and 16 other generics manufacturers, have found themselves in the spotlight after a further multi-state US lawsuit has accused them of participating in a price-fixing conspiracy.
Dr Reddy's Brings In Kikuchi To Lead North America Generics
Dr Reddy’s has added to its senior leadership team by appointing Marc Kikuchi as CEO of North America Generics. With a record number of US launches in Q3, potentially more in store and now a new leader to steer things through, the firm has improved its outlook for a significant revival in earnings. But risks of delays and competition on certain key anticipated launches in 2019 could dull prospects.